147 related articles for article (PubMed ID: 34091621)
1. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
[TBL] [Abstract][Full Text] [Related]
2. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
J Genet; 2024; 103():. PubMed ID: 38736250
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
4. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
5. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
6. The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.
Yang K; Wu Y; Ma Y; Xiao J; Zhou Y; Yin X
Blood Cells Mol Dis; 2020 Sep; 84():102442. PubMed ID: 32387854
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
[TBL] [Abstract][Full Text] [Related]
9. The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.
Jiang Z; Luo HY; Huang S; Farrell JJ; Davis L; Théberge R; Benson KA; Riolueang S; Viprakasit V; Al-Allawi NA; Ünal S; Gümrük F; Akar N; Başak AN; Osorio L; Badens C; Pissard S; Joly P; Campbell AD; Gallagher PG; Steinberg MH; Forget BG; Chui DH
Br J Haematol; 2016 Mar; 172(6):958-65. PubMed ID: 26771086
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
[TBL] [Abstract][Full Text] [Related]
11. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
[TBL] [Abstract][Full Text] [Related]
12. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.
Lai Y; Zhou L; Yi S; Chen Y; Tang Y; Yi S; Yang Z; Wei H; Zheng C; He S
Blood Cells Mol Dis; 2017 Mar; 63():52-57. PubMed ID: 28160732
[TBL] [Abstract][Full Text] [Related]
13. Genetic Modifiers in β-Thalassemia Intermedia: A Study on 102 Iraqi Arab Patients.
Al-Allawi NA; Puehringer H; Raheem RA; Oberkanins C
Genet Test Mol Biomarkers; 2015 May; 19(5):242-7. PubMed ID: 25751242
[TBL] [Abstract][Full Text] [Related]
14. Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.
Badens C; Joly P; Agouti I; Thuret I; Gonnet K; Fattoum S; Francina A; Simeoni MC; Loundou A; Pissard S
Haematologica; 2011 Nov; 96(11):1712-4. PubMed ID: 21791466
[TBL] [Abstract][Full Text] [Related]
15. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.
Danjou F; Anni F; Perseu L; Satta S; Dessì C; Lai ME; Fortina P; Devoto M; Galanello R
Haematologica; 2012 Jul; 97(7):989-93. PubMed ID: 22271886
[TBL] [Abstract][Full Text] [Related]
16. The Impact of XmnI-HBG2, BCL11A and HBS1L-MYB Single Nucleotide Polymorphisms on Hb F Variation of Hematologically Normal Iranian Individuals.
Keyhani E; Jafari Vesiehsari M; Talebi Kakroodi S; Darabi E; Zamani F; Karimlou M; Kamali K; Neishabury M
Hemoglobin; 2016 Jun; 40(3):198-201. PubMed ID: 27117569
[TBL] [Abstract][Full Text] [Related]
17. Utility of the multivariate approach in predicting β-thalassemia intermedia or β-thalassemia major types In Iranian patients.
Banan M; Bayat H; Namdar-Aligoodarzi P; Azarkeivan A; Kamali K; Daneshmand P; Zaker-Kandjani B; Najmabadi H
Hemoglobin; 2013; 37(5):413-22. PubMed ID: 23805990
[TBL] [Abstract][Full Text] [Related]
18. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
[TBL] [Abstract][Full Text] [Related]
19. Correlations between Multiple SNPs and HbF Levels in β-Thalassemia Carriers.
Xu Q; Huang L; Jin T; Han Y; Liu J; Zhang W; Biao Y; An B; Huang S
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702677
[TBL] [Abstract][Full Text] [Related]
20. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]